Abstract:<p>Doxorubicin (DOX) has been widely incorporated in various delivery forms for tareted treatment of malignant tumors such as triple-negative breast cancer (TNBC), with numerous studies reporting higher therapeutic efficacy and lower toxicity at the same time. However, little attention has been paid to whether DOX in a delivery form acts with the same actions and processes as in free form at the cellular level. This question was investigated in the present study wherein DOX conjugated with polyglycerol-coated nanodiamonds through the pH-sensitive hydrazone bond (Nano-DOX) was compared with DOX in free form on the 4T1 mouse TNBC model. We first found Nano-DOX to have a distinct intracellular distribution profile from DOX. Internalized Nano-DOX mainly stayed in the lysosomes slowly releasing DOX into the cytoplasm and then the nucleus whereas DOX displayed both nuclear and lysosomal distribution after cell uptake. Next, Nano-DOX was shown to induce endoplasmic reticulum (ER) stress without substantial DNA damage while DOX caused massive DNA damage as well as ER stress. Consequently, Nano-DOX only caused minimal activation of pro-inflammatory signaling mediated by MAPK/ERK, NF-κB and STAT3 as seen in response to DOX-inflicted DNA damage. Consistently, DOX-induced activities of ABC transporters, CXCL-1, GM-CSF and IL-6, which are tumor protective events downstream to the pro-inflammatory signaling, were also minimal in Nano-DOX-treated cancer cells. These findings are compelling proof that a chemotherapy in nano form can have distinct intracellular pharmacokinetics from its free from, which can result in altered cellular effects of the drug. Implications of these findings are discussed with an emphasis on nano-drug design, tumor pharmacology and chemoresistance.</p>

X-Ray Triggered Release of Doxorubicin from Nanoparticle Drug Carriers for Cancer Therapy

Enhanced Cancer Cell Killing by A Targeting Gold Nanoconstruct with Doxorubicin Payload under X-Ray Irradiation

X-ray-Induced Cherenkov Optical Triggering of Caged Doxorubicin Released to the Nucleus for Chemoradiation Activation

A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy.

A Tumor Mrna-Dependent Gold Nanoparticle-Molecular Beacon Carrier for Controlled Drug Release and Intracellular Imaging.

Gold nanorod-cored biodegradable micelles as a robust and remotely controllable doxorubicin release system for potent inhibition of drug-sensitive and -resistant cancer cells.

Ph and Near-Infrared Light Dual-Stimuli Responsive Drug Delivery Using DNA-conjugated Gold Nanorods for Effective Treatment of Multidrug Resistant Cancer Cells.

Terminal Deoxynucleotidyl Transferase-Catalyzed Preparation of Ph-Responsive DNA Nanocarriers for Tumor-Targeted Drug Delivery and Therapy.

Nanoplatform based on carbon nanoparticles loaded with doxorubicin enhances apoptosis by generating reactive oxygen species for effective cancer therapy

High payload and targeted release of anthracyclines by aptamer-tethered DNA nanotrains - Thermodynamic and release kinetic study

Novel Ph-Triggered Doxorubicin-Releasing Nanoparticles Self-Assembled by Functionalized Β-Cyclodextrin and Amphiphilic Phthalocyanine for Anticancer Therapy.

Ph, Redox and Photothermal Tri-Responsive DNA/polyethylenimine Conjugated Gold Nanorods As Nanocarriers for Specific Intracellular Co-Release of Doxorubicin and Chemosensitizer Pyronaridine to Combat Multidrug Resistant Cancer.

Conjugation with nanodiamonds via hydrazone bond fundamentally alters intracellular distribution and activity of doxorubicin

Loading And Triggered Release Of Cargo From Hollow Spherical Gold Nanoparticle Superstructures

Nanocomplexes of Doxorubicin and DNA Fragments for Efficient and Safe Cancer Chemotherapy.

Aptamer Functionalized Upconversion Nanotheranostic Agent With Nuclear Targeting as the Highly Localized Drug-Delivery System of Doxorubicin

Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis

Dna-Based Ph-Responsive Core-Shell Drug Nanocarrier For Tumor-Targeted Chemo-Photodynamic Therapy

Single Pulse Nanosecond Laser-Stimulated Targeted Delivery of Anti-Cancer Drugs from Hybrid Lipid Nanoparticles Containing 5 nm Gold Nanoparticles.

Tumor Ph-Triggered “charge Conversion” Nanocarriers with On-Demand Drug Release for Precise Cancer Therapy

Doxorubicin hydrochloride-oleic acid conjugate loaded nanostructured lipid carriers for tumor specific drug release.